6 May: 6th Health Industry Meeting for New Aquitaine/Basque Country/Navarre

This year, the 6th Bio-health industry meeting for New Aquitaine/Basque Country/Navarre will be held virtually in Bordeaux as a satellite event of the Meet2Win convention.   Full information HERE   The purpose of the Meetings is to promote cross-border projects with collaboration between industries and researchers from public and private organisations in the health sector from…

Details

OWL and Biosfer join forces to reinforce metabolomics in the diagnosis and treatment of illness

The two companies, representatives of diagnosis solutions based on metabolomic technology, have signed a collaboration agreement to strengthen R&D in the sector. The Basque biotechnology firm OWL will contribute know-how in the creation of non-invasive diagnosis solutions for Non-Alcoholic Steatohepatitis (NASH). The goal is to encourage the use of metabolomic technology in the research and…

Details

Euskadi Next 21-26

This Tuesday, 29/12/2020, the Basque Government approved the first version of the programme Euskadi Next 21-26, for the recovery, transformation and resilience of Euskadi. The Basque Government has drawn up the programme Euskadi Next 21-26 in collaboration with the provincial and local authorities of the three Basque regions, for submission to the Central Government for it to be included in…

Details

Technological solutions for COVID-19: PRAP Euskadi

The PRAP EUSKADI initiative is now available for companies interested in monitoring the incidence of COVID-19 within their organisation. PRAP EUSKADI is an initiative supported by the Department of Economic Development, Sustainability and the Environment of the Basque Government intended to minimise the economic impact that companies in the Basque Country may suffer due to the COVID-19 pandemic. It…

Details

AcceXible, winner of Expansión “Start up” Award, sets up crowdfunding campaign with Crowdcube

The e-Health firm AcceXible, a member of the Basque Health Cluster, has won the Expansión newspaper award in the Health and Biotechnology category sponsored by Novartis-Sandoz. AcceXible has developed a clinically-proven platform that enables the detection and monitoring of mild cognitive deterioration and dementia though speech analysis. The technology of this start-up from Biscay and…

Details

Histocell successfully completes phase I of clinical trial for the treatment of respiratory distress caused by COVID-19

Osakidetza and the Basque bio-pharmaceutical company, Histocell (member of the Basque Health Cluster) have successfully completed the first phase of the clinical trial for the drug HC016 for the treatment of respiratory distress caused by COVID-19. The trial is for the cell therapy drug HC016, developed by Histocell, taking place in collaboration with the Biocruces…

Details

Toyama Pharmaceutical Association – Basque Health Cluster Mission

On 25 November the Toyama Pharmaceutical Association – Basque Health Cluster Mission was launched with a seminar presenting the Basque and Japanese associations, as well as a selection of 4 partner organisations. The mission, with the support of JETRO and ICEX for organisation purposes and co-funded by SPRI, is aimed at building bridges for members…

Details